Patachi, Bogdana, et al. “Pembrolizumab As First-Line Treatment for Recurrent and Metastatic Head and Neck Cancer – Real-World Single-Centre Data”. Acta Oncologica, vol. 64, Jan. 2025, pp. 143-6, doi:10.2340/1651-226X.2025.42128.